tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (TEVA)
NYSE:TEVA

Teva Pharmaceutical (TEVA) Revenue

Compare
7,679 Followers

Teva Pharmaceutical Revenue

Teva Pharmaceutical had a revenue of 4.71B in the quarter ending Dec 31, 2025, with 5.16%. This bring the company's revenue in the last twelve months to 17.26B, Decreased 2.87%. In the fiscal year ending Dec 31, 2025, Teva Pharmaceutical had annual revenue of 17.26B with 4.32% growth.
Revenue (ttm)
17.26B
Revenue Growth
-0.25%
P/S Ratio
2.17
Revenue/Employee
$466,432
Employees
37,000
Market Cap
$37.48B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
17.26B714.00M+104.32%
Dec 31, 2024
16.54B699.00M+104.41%
Dec 31, 2023
15.85B920.00M+106.16%
Dec 31, 2022
14.93B-953.00M+94.00%
Dec 31, 2021
15.88B-781.00M+95.31%
Dec 31, 2020
16.66B-228.00M+98.65%
Dec 31, 2019
16.89B-1.97B+89.57%
Dec 31, 2018
18.85B-3.53B+84.23%
Dec 31, 2017
22.39B